Voyageur Pharmaceuticals CEO Brent Willis from the Proactive newsrooms to share a significant licensing agreement with Rain Cage Carbon to develop nanocarbon-based contrast drugs for medical imaging.

Willis says the partnership aims to develop new contrast agents for the radiology drug market while also making Voyageur the first carbon-neutral pharmaceutical company in the industry.

Willis explains that Rain Cage Carbon's innovative technology allows Voyageur to extract carbon dioxide and other emissions, generating high-grade carbon for various applications. By leveraging this technology, Willis says Voyageur plans to create safer and more effective drugs using carbon 60 molecules.

#ProactiveInvestors #VoyageurPharmaceuticals #MedicalImaging #PharmaceuticalInnovations #NanocarbonTechnology #ContrastDrugs #Radiology #CarbonNeutralPharma #HealthcareBreakthroughs #InnovativePartnerships #MedicalAdvancements #VoyageurPharmaceuticals #RainCage #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

MustGrow Biologics CEO Colin Bletsky joins Natalie Stoberman from the Proactive newsroom to share its how its partnership with Janssen PMP has added an exclusive evaluation to add further research to MustGrow's mustard plant-based technologies.

Bletsky says the partnership with Janssen, a world leader in development and formulation of highly effective active substances and end-use products for the protection of materials and food, brings expertise and support to further research and elevate treatments for post-harvest storage solutions.

MustGrow's natural-based product derived from mustard plants has proven effective in reducing pests, diseases, and fungal to bacterial infections which cause significant annual food loss worldwide.

#ProactiveInvestors #MustGrowBiologics #AgricultureRevolution #FoodWasteSolution #MustardPlantTech #Biotechnology #PostharvestApplications #SustainableFarming #CropProtection #JanssenPartnership #MustGrowBiologics #InnovationInAgriculture #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

SPC Nickel CEO Grant Mourre joined Steve Darling from Proactive to share news the company is continues to uncover key data during its drill program at the West Graham Project in Ontario.

Mourre telling Proactive assay results from Phase 1 of resource definition drilling saw the company find a new high-grade intersection encountered in hole WG-23-042 representing one of the best intersections so far grading 1.71% Ni and 0.46% Cu over 20.0 metres from 286.0 to 306.0 metres. Phase 1 drilling has seen over 5000 metres with 27 holes completed. 11 of those holes are still in the Lab for analysis.

#proactiveinvestors #spcnickelcorp #spcnickel #mining #nickel #westgrahamproject

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Marker Therapeutics Inc CEO Juan Vera joins Natalie Stoberman from the Proactive studios to discuss its latest transaction with CellReady to add a layer of cell and gene therapy manufacturing to its T cell based immunotherapies.

Vera says the recent transaction with CellReady creates the opportunity to outsource manufacturing and technical operations, allowing Marker Therapeutics to focus on clinical developmental programs. Vera adds the transaction also provides the company with $90 million in capital which extends the company's runway until the end of 2025.

Marker Therapeutics is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets.

#ProactiveInvestors #MarkerTherapeutics #CancerTreatment #Immunotherapy #TCellTherapy #HealthcareInnovation #ClinicalStudies #BiotechAdvancements #CEOInterview #MedicalResearch #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

NovaBay Pharmaceuticals CEO Justin Hall joined Steve Darling from Proactive to talk more about the company that has developed scientifically proven eyecare, skincare and wound care products. The company top product is Avenova which has proven in laboratory testing to have broad antimicrobial properties as it removes foreign material and debris from the skin around the eye, including the eyelid.

Hall telling Proactive the company acquired DermaDoctor, a skincare brand, in 2021. Hall emphasizes that all their products are doctor-recommended and clinically developed to address specific needs. NovaBay aims to excel in all three verticals, which includes wound care and expects continued growth and success.

#proactiveinvestors #novabaypharmaceuticals #nyseamerican #nby #biopharma #eyecare #woundcare #woundcare #EyeCareRevolution #NovaBayPharmaceuticals #AntimicrobialTechnology #SkincareInnovation #WoundCareSolutions #HealthcareBreakthrough #ClinicalProducts #DoctorRecommended #SafeEyeCare #InnovativeSkincare #OptimalWellness #PrescriptionProducts

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Fineqia International Inc (CSE:FNQ OTC:FNQQF) CEO Bundeep Singh Rangar visits the Proactive London studio to speak with Thomas Warner about the unique role he believes Fineqia is playing in the nascent digital asset industry.

Bundeep reveals what he thinks makes Fineqia attractive to investors looking for exposure to the fast-moving digital economy, and says that subdued valuations and high growth potential mean that "now is the time to invest."

#ProactiveInvestors #FNQ #FNQQF #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nextech3D.AI CEO Evan Gappelberg joined Steve Darling from Proactive to share news the company has announced the propsed spinout of Toggle3D.ai is set for June 13th. The company will be listed on the Canadian Securities Exchange using the ticker “TGGL”

Gappelberg telling Proactive Toggle3D.ai is a SaaS solution that utilizes generative AI to convert CAD files, apply 4K texturing, and enable seamless publishing of superior 4K 3D models, serving various industries. After the IPO spin-out Nextech3D.ai is going to retain 13 million shares or about a 50% ownership stake in Toggle3D.ai.

#proactiveinvestors #nextech3d.ai #cse #NTAR #otcqb #metaverse #toggle3d

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Voyager Life PLC (AQSE:VOY) chief executive Nick Tulloch speaks to Proactive's Thomas Warner after releasing an operations update focused on the integration of the company's newly-acquired CBD extraction and manufacturing facility in Poland.

Tulloch suggests that talks are ongoing for orders on a scale not previously achieved by Voyager Life - talks made possible by its newfound ability to deal with "international and multinational customers."

#ProactiveInvestors #VoyagerLife #VOY #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #CBD

Esker COO Emmanuel Olivier joins Natalie Stoberman from the Proactive studios to discuss how the company's expertise in software and its global cloud platform for the financial and customer service sectors have been expanding throughout Europe, North America and beyond.

Olivier says Esker helps clients digitize and automate their back-office functions by eliminating paper processes and leveraging AI technology for increased efficiency. He adds that Esker aims for consistent organic growth of around 15 percent annually, prioritizing sustainable expansion and profitability to provide integrated solutions for its customers. While headquartered in France, Olivier says the company has focused on the U.S. market for business development that has been contributing over 40 percent of its revenue.

#ProactiveInvestors #EskerSA #CloudPlatform #BackOfficeAutomation #DigitalTransformation #AIinBusiness #FinancialServices #CustomerService #EfficiencySolutions #PaperlessOffice #GlobalBusiness #TechInnovation #ProductivityBoost #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Delivra Health Brands President and CEO Gord Davey joins Natalie Stoberman from the Proactive studios to share the how the company's Q3 financial and operational results have been able to repeat a positive EBITDA for the second straight quarter.

Davey says the company's focus on increasing revenue, reducing costs, and improving margins has been the driver in steady growth and recording a positive EBITDA performance. Davey adds Delivra continues to execute its strategies by expanding its business in the U.S. and international markets, introducing new products in both Dream Water and LivRelief lines, and investing in marketing efforts and ongoing innovation.

#DelivraHealthBrands #Q3Results #PositiveEBITDA #HealthIndustry #Innovation #BusinessGrowth #Healthcare #HealthProducts #DreamWater #LivRelief #MarketingEfforts #FinancialHighlights #CompanyUpdates #CEOInterview #HealthBrands #HealthcareIndustry #Investment #RevenueGrowth #CostReduction #BrandSuccess #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews